Key verticals adopting pericarditis drugs include: - Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi, Bayer AG, Mylan N.V., AstraZeneca PLC, Amgen Inc., Eli Lilly and Company, Genentech, Inc.